Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 11.371% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CC1CCC2(C)C3=C(CCC3)CC[N+]2(C)C1.[I-]
b.) CCOc1ccc(NC(=NCc2ccc3c(c2)OCO3)SC2CC(=O)N(c3ccccc3)C2=O)cc1
c.) COc1ccc(NC(=O)c2ccc(CN3CCc4ccccc4C3)cc2)cc1OC
Answer: c. COc1ccc(NC(=O)c2ccc(CN3CCc4ccccc4C3)cc2)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=O)c2ccc(CN3CCc4ccccc4C3)cc2)cc1OC
COc1ccc(NC(=O)c2ccc(CN3CCc4ccccc4C3)cc2)cc1OC
4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-N-(3,4-dimethoxyphenyl)benzamide